Compared to CD103-CD8+ T cells, CD103+CD8+ T cells express higher levels of PD-1, GZMB, and IFN-γ in TLSs.89 Consequently, they are a predictive marker for the effectiveness of ICB treatment in gastric cancer.97 This evidence concerns the gene CD8A and gastric cancer.